Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $113,820.82 -1.05%
Ethereum $4,087.54 -2.82%
BNB $1,135.53 -1.62%
Optimism $0.45 -3.95%
Arbitrum $0.33 -4.38%
Solana $200.99 -1.33%
Polygon $0.22 +2.77%
Cosmos $3.15 -3.05%
Avalanche $20.19 -2.99%

Bitcoin $113,820.82 -1.05%
Ethereum $4,087.54 -2.82%
BNB $1,135.53 -1.62%
Optimism $0.45 -3.95%
Arbitrum $0.33 -4.38%
Solana $200.99 -1.33%
Polygon $0.22 +2.77%
Cosmos $3.15 -3.05%
Avalanche $20.19 -2.99%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B